Complete the form below and we will email you a PDF version of
Would you like to receive further email communication from Technology Networks?
ProtoKinetix owns the world-wide rights to a family of anti-aging glycoproteins, trademarked as AAGPs™. In clinical tests AAGPs™ have demonstrated the ability to enhance the health and extend the life of biologically sensitive cells which have been subjected to severe stress conditions under laboratory controlled tests. AAGPs™ are stable and non-toxic.